SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (1136)6/7/2003 3:32:43 AM
From: Icebrg  Respond to of 1834
 
>> so strike while the iron is hot, since it may dry up again just as quickly>>

You mean they take it just because they can, not because they have a need for it?

Anyhow, if they complete the transaction they should be well provided for even in the case of an Indiplon disaster. The dilutive cost for this transaction should be somewhere between 10 and 15 %. That sounds acceptable to me.

Erik


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News